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Carcinogenesis: A balance between b-catenin and APC
Barry M. Gumbiner
A protein first identified by its association with cadherin
cell adhesion molecules, b-catenin, has been implicated
in carcinogenesis. In a number of different types of
cancer, signalling through b-catenin is upregulated either
by direct mutation of b-catenin or loss of negative
regulation by the APC tumor suppressor protein.
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The discovery of the adenomatous polyposis coli (APC)
tumor suppressor gene was a major breakthrough for
understanding the genesis of colorectal cancer [1]. Muta-
tions in this gene not only lead to the development of
familial colon cancer, but also are associated with the vast
majority of cases of sporadic colorectal cancer. The pre-
dicted amino acid sequence of the ~300 kD protein
encoded by the APC gene revealed little about its possible
cellular function. However, a search for interacting pro-
teins turned up an important lead: it associates in the cyto-
plasm with b-catenin, a polypeptide that binds to the
cytoplasmic domain of the cadherin cell adhesion mole-
cules and is required for effective cell–cell adhesion [2,3].
Because of the established function of b-catenin in
cadherin-mediated cell adhesion, it was proposed initially
that APC mutations contribute to the development of
colon cancer because of their effects on intestinal cell
adhesion and migration, processes important for the con-
tinual renewal of the intestinal lining. It has become clear,
however, that b-catenin has a second role in the cell, as a
mediator of signal transduction events that alter gene
expression during important developmental processes
[4,5]. Indeed, several recent papers [6–8] have now
reported that activation of b-catenin signaling, either by
APC inactivation or mutations in b-catenin, plays a key
role in both colon cancer and melanoma. Moreover, APC
has been found to regulate b-catenin-mediated changes in
gene transcription. Although it remains possible that APC
has a role in cell adhesion and cell migration in the colon
[9], these findings provide an even more compelling
model for the role of APC in carcinogenesis.
The b-catenin protein and its Drosophila homologue,
Armadillo, are required for the transduction of signals
initiated by Wnt growth factors (Wingless in Drosophila)
[4,5,10]. Armadillo is a segment polarity gene important for
the anteroposterior patterning of the cuticle during
Drosophila embryogenesis. In Xenopus, b-catenin is
required for an early step in the induction of the
dorsal–ventral and anterior–posterior axes of the embryo.
The overall organization of the Wingless and Wnt
pathways in these two species is remarkably similar,
involving many of the same components all along the
pathway (Figure 1).
A key component in both Wingless and Wnt pathways is
the serine/threonine kinase known as glycogen synthase
kinase (GSK) in vertebrates, or Zeste-white-3 or Shaggy in
Drosophila, which inhibits downstream signal transduction
through b-catenin. Curiously, in Xenopus it is still uncer-
tain whether Wnt and the initial receptor-mediated events
— which act via the receptor Frizzled and Dishevelled —
are actually involved in normal development, even though
they can induce body axis formation [11,12]. Instead, one
of the more downstream components of the pathway may
be activated by cytoplasmic rearrangements during the
cortical rotation that is a very early event following fertil-
ization of the egg. Nevertheless, the entire Wnt pathway
is functional in Xenopus and it is remarkably similar to the
Wingless pathway in Drosophila.
Cadherins and cell adhesion do not seem to be directly
involved in signal transduction by b-catenin. Several
experiments using various mutant forms of b-catenin and
Armadillo have shown that their adhesion and signal trans-
ducing functions are separable [5,13]. Cadherins can,
however, act upstream of b-catenin to regulate its signal-
ing activity [13,14]. Sequestration of b-catenin to the
membrane by binding to overexpressed cadherin strongly
inhibits its signaling activity in both Xenopus and
Drosophila.  In some circumstances, therefore, cadherins
and/or cell adhesion changes might control the signaling
activity of b-catenin in parallel to, or instead of, Wnt
receptor activity.
An important breakthrough for understanding the
mechanism of signal transduction by b-catenin and
Armadillo came with the discovery that they act through
an interaction  with a transcription factor called leukocyte
enhancing factor 1 (LEF-1) or T-cell factor (TCF). In
Xenopus, TCF/LEF has been implicated in induction of
the dorsal–ventral and anterior–posterior body axes by
Wnt and b-catenin [15,16]. A strong candidate for a target
gene for TCF/LEF in Xenopus is siamois, whose expres-
sion is directly induced by Wnt and b-catenin and which
itself induces axis formation [17,18].
In Drosophila, the TCF/LEF homologue was identified in
a genetic screen for wingless-like phenotype as a gene
called pangolin, and shown to be required downstream of
armadillo in Wingless signaling [19–21]. For the part wing-
less plays in segmentation, the relevant gene targets for
TCF/LEF probably include engrailed, which is expressed
in a narrow stripe of cells neighboring the stripe of
wingless-expressing cells. A natural promoter for
TCF/LEF-mediated Wnt/Wingless signaling has been
identified in the homeotic gene Ultrabithorax (Ubx). The
expression of Ubx in the visceral mesoderm of Drosophila
depends on both wingless and decapentaplegic (dpp), which
encodes a member of the transforming growth factor-b
(TGF-b) family of growth factors. Thus, the role of the b-
catenin–TCF/LEF interaction in the Wnt pathway is now
well established for many different signaling events.
The mechanism by which b-catenin/Armadillo regulates
transcriptional activity of TCF/LEF is unknown, but
several models have been proposed. TCF/LEF is a
member of the HMG family of transcription factors,
defined by the presence of a domain of a type first identi-
fied in a class of high mobility group (HMG) proteins.
HMG domains are thought to have an architectural role in
the control of gene expression; the idea is that, by bending
DNA, they control the juxtaposition of factors bound to
different sites on the gene. Indeed, there is evidence that
b-catenin alters DNA bending induced by TCF/LEF
[15]. Alternatively, b-catenin may be part of a trans-acti-
vating transcriptional complex that is recruited to the
DNA by binding to TCF/LEF; the analysis of artificial
synthetic promoters containing multiple HMG binding
sites in vitro provides some evidence for this model [16]. 
Analysis of the natural promoter for TCF/LEF in the Ubx
gene suggests a more complicated mechanism [20]. Ubx
expression depends on both Wingless and Dpp, which act
through two different regions of the promoter. TCF/LEF
binds to the Wingless-response sequence, which forms a
stable complexes with TCF/LEF and Armadillo. The Dpp-
response sequence in the Ubx promoter is adjacent to the
TCF/LEF binding site, suggesting that two sets of tran-
scriptional complexes must interact in some way to trigger
expression of Ubx. A DNA bending model could explain
these findings. Finally, it even remains possible that b-
catenin regulates TCF/LEF function at a site distant from
the target gene, for example by controlling the nuclear
localization of TCF/LEF in response to the Wnt signal.
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Figure 1
Comparison of b-catenin-TCF/LEF-dependent
signaling in Drosophila, Xenopus, and human
colon cancer cells. In Drosophila:
components of the Wingless pathway and
their ordering were determined genetically.
The accumulation of Armadillo, the b-catenin
homologue, correlates with signaling, but
preliminary findings suggest that APC is not
involved in regulating Armadillo accumulation
or signaling. In Xenopus: the vertebrate Wnt
pathway is highly homologous to the
Wingless pathway and leads to induction of
the dorsal–ventral and anterior–posterior
embryonic axes. All components mediate
signaling in Xenopus, but upstream
components shown in faint typeface may not
participate in normal embryonic development.
APC stimulates signal transduction through b-
catenin–TCF/LEF in this case. In human
cancer cells: APC was originally identified as
a tumor suppressor in human colorectal
cancer; it downregulates b-catenin levels and
inhibits b-catenin–TCF/LEF-dependent
signaling; moreover, b-catenin mutations are
associated with oncogenesis in colorectal
cancer and melanoma. Cadherin: this cell–cell
adhesion molecule is the major b-catenin
associated protein in the cell, and high levels
of expression inhibit signal transduction by b-
catenin.
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Given that the APC protein interacts with b-catenin, is it
possible that its role as a tumor suppressor stems from its
ability to regulate the Wnt pathway? Earlier findings have
implicated APC in certain aspects of the Wnt pathway. In
many colon tumor cell lines, expression of wild-type APC
can decrease the levels of b-catenin by stimulating its rate
of degradation [22]. Moreover, APC seems to be a very
good substrate for phosphorylation by GSK [23]. In
Xenopus embryos, expression of APC has similar effects to
Wnts or b-catenin — induction of the dorsal–ventral and
anterior–posterior body axes and the expression of the
siamois gene [24].
In a more recent study [6], the role of APC in regulating
gene expression in tumor cells was tested directly by
assaying for TCF/LEF-dependent gene activation. A syn-
thetic reporter gene construct having several TCF/LEF
binding sites in the promoter was introduced into various
colon tumor cell lines. In cells expressing severely
mutated forms of APC, the reporter gene was constitu-
tively transcribed. Importantly, when wild-type APC was
introduced into the cells, it suppressed transcription of the
reporter gene. Severely mutated forms of APC failed to
suppress transcription of the reporter gene, and the abili-
ties of various mutant forms of APC to suppress transcrip-
tion correlated with their tumor suppressor activities in
human colon cancer. In these tumor cells, therefore, APC
acts to inhibit the transcriptional activity mediated by b-
catenin and TCF/LEF, and the loss of this ability by
mutations in APC accounts for the loss of its tumor sup-
pressor activity.
APC mutations are found in most colorectal tumors, but
not all of them. Do other components of this signaling
pathway also contribute to colon carcinogenesis? Indeed,
many colon tumor cell lines have been found to harbor
specific mutations in b-catenin that lead to its accumula-
tion in the cytosol and enhanced TCF/LEF-dependent
transcriptional activity [7]. Interestingly, these mutations
occur at specific serine residues in the amino-terminal
region of b-catenin, which are thought to regulate b-
catenin turnover and to be phosphorylated, directly or
indirectly, by GSK [10]. Similarly, both inactivating APC
mutations and activating b-catenin mutations occur in a
large number of melanomas [8], suggesting that the same
oncogenic and tumor suppressor relationship between
these two molecules is common to other types of tumor.
Thus, b-catenin seems to act as an oncogene product that
opposes the tumor suppressor function of APC within the
same biochemical pathway. 
The favored explanation for the biochemical mechanism
underlying the tumor suppressor activity of APC is that it
regulates the levels of b-catenin in the cytosol by control-
ling its degradation [5,8,10,22]. In many tumor cell lines,
either the loss of APC function or oncogenic b-catenin
mutations leads to b-catenin accumulation in the cytosol.
Also, Armadillo protein accumulates to high levels in
response to the Wingless signal, suggesting an analogous
mechanism. However, the role of APC in the Wnt
pathway and its biochemical mechanism of action are
incompletely understood. For instance, Wnts have not yet
been implicated in colon cancer; hence it is conceivable
that APC participates in additional signaling pathways. 
Studies in Drosophila have similarly failed to reveal a role
for APC in the Wingless pathway, even though they
demonstrate an essential role for APC in embryogenesis
[25]. Moreover, while it is clear that APC negatively regu-
lates b-catenin-dependent transcription in colon tumor
cell lines, as mentioned above, it has an activating activity
in the Xenopus embryo, inducing siamois expression and
body axis formation [24]. This suggests that APC may
have a important signaling function in addition to its role
in regulating b-catenin levels. Correspondingly, changes
in the levels of b-catenin are not always associated with
increased expression of APC [26]. As APC is a large,
complex protein with a diversity of domains, several b-
catenin binding sites, and different phosphorylation states,
it would not surprising if it had diverse roles in signal
transduction. 
The common feature of all the signal transduction events
described above is the role of b-catenin in regulating gene
expression through the transcription factor TCF/LEF-1.
The upstream mechanisms that regulate these events may
be varied. Activation of the Wnt receptor may or may not be
the initiating event, and in some circumstances cadherins
may play a role in regulating the signaling activity of b-
catenin. APC is clearly implicated in regulating b-catenin
and TCF activity in some, but perhaps not all circum-
stances, and it may have additional signaling roles yet to be
discovered. Nonetheless, it is clear that signal transduction
mechanisms involving b-catenin are turning out to be wide-
spread events in developmental and cancer cell biology.
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